A Survey of Synthetic Cannabinoid Consumption by Current Cannabis Users
- 1 April 2014
- journal article
- research article
- Published by SAGE Publications in Substance Abuse
- Vol. 35 (2) , 184-189
Abstract
Background: Despite growing concern about the increased rates of synthetic cannabinoid (SC) use and their effects, only limited data are available that addresses these issues. This study assessed the extent of SC product use and reported effects among a cohort of adult marijuana and tobacco users. Methods: A brief telephone interview was conducted with individuals who had given permission to be contacted for future research while screening for a cannabis/nicotine dependence medication development study (NCT01204723). Results: Respondents ( N = 42; 88% participation rate) were primarily young adults, male, racially diverse, and high school graduates. Nearly all currently smoked tobacco and cannabis, with 86% smoking cannabis on 5 or more days per week. Nearly all (91%) were familiar with SC products, half (50%) reported smoking SC products previously, and a substantial minority (24%) reported current use (i.e., past month). Despite a federal ban on 5 common SCs, which went into effect on March 1, 2011, a number of respondents reported continued SC product use. Common reasons reported for use included, but were not limited to, seeking a new “high” similar to that produced by marijuana and avoiding drug use detection via a positive urine screen. The primary side effects were trouble thinking clearly, headache, dry mouth, and anxiety. No significant differences were found between synthetic cannabinoid product users (ever or current) and nonusers by demographics or other characteristics. Conclusions: Among current marijuana and tobacco users, SC product consumption was common and persisted despite a federal ban. The primary reasons for the use of SC-containing products seem to be to evade drug detection and to experience a marijuana-like high.Keywords
This publication has 18 references indexed in Scilit:
- Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findingsAddiction, 2012
- A survey study to characterize use of Spice products (synthetic cannabinoids)Drug and Alcohol Dependence, 2012
- Synthetic cannabinoid JWH-018 and psychosis: An explorative studyDrug and Alcohol Dependence, 2011
- A Teenager With AgitationPediatric Emergency Care, 2010
- The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodesSchizophrenia Research, 2010
- Primary Care Validation of a Single-Question Alcohol Screening TestJournal of General Internal Medicine, 2009
- ‘Spice’ and other herbal blends: harmless incense or cannabinoid designer drugs?Journal of Mass Spectrometry, 2009
- Comparison of cannabis and tobacco withdrawal: Severity and contribution to relapseJournal of Substance Abuse Treatment, 2008
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarinBritish Journal of Pharmacology, 2008
- The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: Reliability, validity and diagnostic cut-offDrug and Alcohol Dependence, 2006